These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 9088889

  • 1. Combined antibody screening for improved prediction of IDDM--modern strategies.
    Roll U, Ziegler AG.
    Exp Clin Endocrinol Diabetes; 1997; 105(1):1-14. PubMed ID: 9088889
    [No Abstract] [Full Text] [Related]

  • 2. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C, Hatziagelaki E, Stroedter A, Becker F, Scherer S, Petzoldt R, Federlin K, Bretzel RG.
    Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
    [Abstract] [Full Text] [Related]

  • 3. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF.
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [Abstract] [Full Text] [Related]

  • 4. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
    Ongagna JC, Levy-Marchal C.
    Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905
    [Abstract] [Full Text] [Related]

  • 5. [Autoantibodies in type 1 diabetes mellitus].
    Ziegler M, Ziegler B.
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261
    [No Abstract] [Full Text] [Related]

  • 6. [Antibodies to glutamic acid decarboxylase (GADA) as markers of risk for development of insulin-dependent diabetes mellitus].
    Kretowski A, Szelachowska M, Kowalska I, Peczyńska J, Urban M, Kinalska I.
    Przegl Lek; 1998 Aug; 55(6):315-9. PubMed ID: 9857706
    [Abstract] [Full Text] [Related]

  • 7. [Islet autoantibody assays in type I diabetes: superiority of passage from use of ICA to traditional tests].
    Lazar D, Weintrob N, Abramov N, Assa S, Bloch K, Ofan R, Ben-Zaken H, Vardi P.
    Harefuah; 1998 May 01; 134(9):678-81, 750. PubMed ID: 10909610
    [Abstract] [Full Text] [Related]

  • 8. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
    Schmidli RS, Colman PG, Harrison LC.
    J Autoimmun; 1994 Dec 01; 7(6):873-9. PubMed ID: 7888043
    [Abstract] [Full Text] [Related]

  • 9. [Prevalence and predictive value of islet cell autoantibodies and anti-glutamic acid decarboxylase in a family study in Lyons].
    Thivolet C.
    Journ Annu Diabetol Hotel Dieu; 1992 Dec 01; ():165-71. PubMed ID: 1495236
    [No Abstract] [Full Text] [Related]

  • 10. [Cytoplasmic islet cell antibodies and GAD antibodies in diagnosis of diabetes].
    Bieg S, Seissler J, Scherbaum WA.
    Med Klin (Munich); 1995 Oct 15; 90(10):594-8. PubMed ID: 7500923
    [No Abstract] [Full Text] [Related]

  • 11. Islet autoantibodies and their use in predicting insulin-dependent diabetes.
    Bonifacio E, Bingley PJ.
    Acta Diabetol; 1997 Oct 15; 34(3):185-93. PubMed ID: 9401639
    [No Abstract] [Full Text] [Related]

  • 12. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S, Byron SL, Tuomilehto J, Zimmet PZ, Myers MA, Vidgren G, Rowley MJ, Feeney SJ, Koskela P, Tuomilehto-Wolf E, Mackay IR.
    Diabet Med; 1997 Aug 15; 14(8):678-85. PubMed ID: 9272595
    [Abstract] [Full Text] [Related]

  • 13. [Prediction of type I diabetes by antibody screening].
    Roll U, Ziegler AG.
    Fortschr Med; 1995 Sep 20; 113(26):365-7. PubMed ID: 7498855
    [Abstract] [Full Text] [Related]

  • 14. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes.
    Mayrhofer M, Rabin DU, Messenger L, Standl E, Ziegler AG.
    Exp Clin Endocrinol Diabetes; 1996 Sep 20; 104(3):228-34. PubMed ID: 8817240
    [Abstract] [Full Text] [Related]

  • 15. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
    Kretowski A, Kowalska I, Peczyńska J, Urban M, Kinalska I.
    Przegl Lek; 2000 Sep 20; 57(3):143-6. PubMed ID: 10909282
    [Abstract] [Full Text] [Related]

  • 16. [Islet cell antibodies].
    Hanafusa T.
    Rinsho Byori; 1995 May 20; 43(5):460-2. PubMed ID: 7783363
    [Abstract] [Full Text] [Related]

  • 17. Antibodies as predictors of type 1 diabetes.
    Wilkin TJ.
    Compr Ther; 1991 Jul 20; 17(7):3-10. PubMed ID: 1742966
    [No Abstract] [Full Text] [Related]

  • 18. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    Seissler J, Amann J, Mauch L, Haubruck H, Wolfahrt S, Bieg S, Richter W, Holl R, Heinze E, Northemann W.
    J Clin Invest; 1993 Sep 20; 92(3):1394-9. PubMed ID: 8376591
    [Abstract] [Full Text] [Related]

  • 19. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus.
    Bingley PJ, Bonifacio E, Gale EA.
    Lancet; 1994 Jul 23; 344(8917):266-7. PubMed ID: 7913179
    [No Abstract] [Full Text] [Related]

  • 20. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers.
    Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA.
    Diabetes; 1997 Nov 23; 46(11):1701-10. PubMed ID: 9356015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.